The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction
Open accessAbstract
The traditional view is that cancer cells predominately produce ATP by glycolysis, rather than by oxidation of energy-providing substrates. Mitochondrial uncoupling--the continuing reduction of oxygen without ATP synthesis--has recently been shown in leukemia cells to circumvent the ability of oxygen to inhibit glycolysis, and may promote the metabolic preference for glycolysis by shifting from pyruvate oxidation to fatty acid oxidation (FAO). Here we have demonstrated that pharmacologic inhibition of FAO with etomoxir or ranolazine inhibited proliferation and sensitized human leukemia cells--cultured alone or on bone marrow stromal cells--to apoptosis induction by ABT-737, a molecule that releases proapoptotic Bcl-2 proteins such as Bak from antiapoptotic family members. Likewise, treatment with the fatty acid synthase/lipolysis inhibitor orlistat also sensitized leukemia cells to ABT-737, which supports the notion that fatty acids promote cell survival. Mechanistically, we generated evidence suggesting that FAO regulates the activity of Bak-dependent mitochondrial permeability transition. Importantly, etomoxir decreased the number of quiescent leukemia progenitor cells in approximately 50% of primary human acute myeloid leukemia samples and, when combined with either ABT-737 or cytosine arabinoside, provided substantial therapeutic benefit in a murine model of leukemia. The results support the concept of FAO inhibitors as a therapeutic strategy in hematological malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 1×
“A NA BMA AML Hyperdiploid metaphase 47,XY,+8[1]; Diploid male karyotype 46,XY[19] B 55 BMA AML M1 46,XY[20] C 77 BMA AML M4 Diploid female karyotype //46,XX[20] D 70 BMA AML Not done E 95 BMA AML M0 46XX[20] F 30 BMA AML M4 Hyperdiploid clone 47,XY,+21c[20] G 94 PB AML M5B 46,xx,add(6)(p23)[11]/46,xx[9] H 95 PB AML M1…”
BackgroundAn inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108
Bonnet, S., Archer, S. L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.020 · Cited by 1,530
Certo, M., Moore, V. D. G., Nishino, M., Wei, G., Korsmeyer, S., Armstrong, S. A., & Letai, A. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.027 · Cited by 1,288
Energy metabolism in tumor cells
Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Marín‐Hernández, A., & Saavedra, E. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05686.x · Cited by 1,082
Konopleva, M., Contractor, R., Tsao, T., Samudio, I., Ruvolo, P. P., Kitada, S., Deng, X., Zhai, D., Shi, Y.-X., Sneed, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.006 · Cited by 1,023
Self-citationMitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone.
Wilson-Fritch, L., Nicoloro, S., Chouinard, M., Lazar, M. A., Chui, P. C., Leszyk, J., Straubhaar, J., Czech, M. P., & Corvera, S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21752 · Cited by 616
A critical role of neural-specific JNK3 for ischemic apoptosis
Kuan, C.-Y., Whitmarsh, A. J., Yang, D. D., Liao, G., Schloemer, A. J., Dong, C., Bao, J., Banasiak, K. J., Haddad, G. G., Flavell, R. A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336254100 · Cited by 409
MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy
Kojima, K., Konopleva, M., Samudio, I. J., Shikami, M., Cabreira-Hansen, M., McQueen, T., Ruvolo, V., Tsao, T., Zeng, Z., Vassilev, L. T., et al. (2005) · Blood · doi:10.1182/blood-2005-02-0553 · Cited by 407
Self-citationThe role of mesenchymal stem cells in haemopoiesis
Dazzi, F., Ramasamy, R., Glennie, S., Jones, S. P., & Roberts, I. (2006) · Blood Reviews · doi:10.1016/j.blre.2005.11.002 · Cited by 361
Paumen, M. B., Ishida, Y., Muramatsu, M., Yamamoto, M., & Honjo, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3324 · Cited by 349
Zhang, C.-Y., Parton, L. E., Ye, C. P., Krauss, S., Shen, R., Lin, C.-T., Porco, J. A., & Lowell, B. B. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.010 · Cited by 332
The Warburg effect and its cancer therapeutic implications
Chen, Z., Lu, W., Garcia-Prieto, C., & Huang, P. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9086-x · Cited by 318
Guan, Y., Gerhard, B., & Hogge, D. E. (2003) · Blood · doi:10.1182/blood-2002-10-3062 · Cited by 293
Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins
Chipuk, J. E., Fisher, J. C., Dillon, C. P., Kriwacki, R. W., Kuwana, T., & Green, D. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808036105 · Cited by 246
YOUNG, M. E., PATIL, S., YING, J., DEPRE, C., SINGH AHUJA, H., SHIPLEY, G. L., STEPKOWSKI, S. M., DAVIES, P. J. A., & TAEGTMEYER, H. (2001) · The FASEB Journal · doi:10.1096/fj.00-0351com · Cited by 223
Self-citationPecqueur, C., Bui, T., Gelly, C., Hauchard, J., Barbot, C., Bouillaud, F., Ricquier, D., Miroux, B., & Thompson, C. B. (2008) · The FASEB Journal · doi:10.1096/fj.07-8945com · Cited by 209
Tabe, Y., Jin, L., Tsutsumi-Ishii, Y., Xu, Y., McQueen, T., Priebe, W., Mills, G. B., Ohsaka, A., Nagaoka, I., Andreeff, M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3166 · Cited by 193
Self-citationCardiac Metabolism as a Target for the Treatment of Heart Failure
Taegtmeyer, H. (2004) · Circulation · doi:10.1161/01.cir.0000139340.88769.d5 · Cited by 178
Self-citationCharacterization of a novel metabolic strategy used by drug‐resistant tumor cells
Harper, M., Antoniou, A., Villalobos‐Menuey, E., Russo, A., Trauger, R., Vendemelio, M., George, A., Bartholomew, R., Carlo, D., Shaikh, A., et al. (2002) · The FASEB Journal · doi:10.1096/fj.02-0541com · Cited by 172
Konopleva, M., Zhao, S., Hu, W., Jiang, S., Snell, V., Weidner, D., Jackson, C. E., Zhang, X., Champlin, R., Estey, E., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03637.x · Cited by 171
Self-citationRuffolo, S. C., & Shore, G. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302930200 · Cited by 170
Samudio, I., Fiegl, M., McQueen, T., Clise-Dwyer, K., & Andreeff, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0555 · Cited by 168
Self-citationLeinninger, G. M., Backus, C., Sastry, A. M., Yi, Y., Wang, C.-W., & Feldman, E. L. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.017 · Cited by 138
Befroy, D. E., Petersen, K. F., Dufour, S., Mason, G. F., Rothman, D. L., & Shulman, G. I. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808889105 · Cited by 133
Pizer, E. S., Wood, F. D., Pasternack, G. R., & Kuhajda, F. P. (1996) · PubMed · Cited by 132
Improved energy homeostasis of the heart in the metabolic state of exercise
Goodwin, G. W., Taegtmeyer, H., & Guthrie), (. T. T. A. O. P. H. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.4.h1490 · Cited by 130
Self-citationMacInnes, A., Fairman, D. A., Binding, P., Rhodes, J. A., Wyatt, M. J., Phelan, A., Haddock, P. S., & Karran, E. H. (2003) · Circulation Research · doi:10.1161/01.res.0000086943.72932.71 · Cited by 126
Kojima, K., Shimanuki, M., Shikami, M., Samudio, I. J., Ruvolo, V. R., Corn, P. G., Hanaoka, N., Konopleva, M. Y., Andreeff, M., & Nakakuma, H. (2008) · Leukemia · doi:10.1038/leu.2008.158 · Cited by 124
Self-citationPallasch, C. P., Schwamb, J., Königs, S., Schulz, A., Debey, S., Kofler, D. M., Schultze, J. L., Hallek, M. J., Ultsch, A., & Wendtner, C.-M. (2007) · Leukemia · doi:10.1038/sj.leu.2405058 · Cited by 102
Acute effect of fatty acids on metabolism and mitochondrial coupling in skeletal muscle
Hirabara, S. M., Silveira, L. R., Alberici, L. C., Leandro, C. V. G., Lambertucci, R. H., Polimeno, G. C., Cury‐Boaventura, M. F., Procópio, J., Vercesi, A. E., & Curi, R. (2005) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2005.11.007 · Cited by 97
Potentiation of chemotherapeutic drugs by energy metabolism inhibitors 2‐deoxyglucose and etomoxir
Hernlund, E., Ihrlund, L. S., Khan, O. M., Ateş, Y. Ö., Linder, S. T., Panaretakis, T., & Shoshan, M. C. (2008) · International Journal of Cancer · doi:10.1002/ijc.23525 · Cited by 91
Palmitate induces apoptosis via a direct effect on mitochondria
PABLO, M. A. D., Susín, S. A., Jacotot, E. D., Larochette, N., Costantini, P., Ravagnan, L., Zamzami, N., & Kroemer, G. (1999) · APOPTOSIS · doi:10.1023/a:1009694124241 · Cited by 88
Jin, J., Hou, Q., Mullen, T. D., Zeidan, Y. H., Bielawski, J., Kraveka, J. M., Bielawska, A. E., Obeid, L. M., Hannun, Y. A., & Hsu, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801597200 · Cited by 83
Giordano, A., Calvani, M., Petillo, O., Grippo, P., Tuccillo, F. M., Melone, M. A. B., Bonelli, P., Calarco, A., & Peluso, G. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401636 · Cited by 75
Cabrero, À., Alegret, M., Sánchez, R. M., Adzet, T., Laguna, J. C., & Vázquez‐Carrera, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110321200 · Cited by 71
Die Rolle der Phosphors�ure bei Dehydrierungsvorg�ngen und ihre biologische Bedeutung
Lynen, F. (1942) · Die Naturwissenschaften · doi:10.1007/bf01475305 · Cited by 71
Characterization of Hepatic Mitochondrial Injury Induced by Fatty Acid Oxidation Inhibitors
Vickers, A. E. M. (2009) · Toxicologic Pathology · doi:10.1177/0192623308329285 · Cited by 66
Samudio, I., Konopleva, M., Pelicano, H., Huang, P., Frolova, O., Bornmann, W., Ying, Y., Evans, R., Contractor, R., & Andreeff, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.018051 · Cited by 58
Self-citationTargeting the Leukemia Microenvironment
Konopleva, M. Y., & Andreeff, M. (2007) · Current Drug Targets · doi:10.2174/138945007780830827 · Cited by 58
Self-citationModified glutamine catabolism in macrophages of Ucp2 knock-out mice
Nübel, T., Emre, Y., Rabier, D., Chadefaux, B., Ricquier, D., & Bouillaud, F. (2007) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2007.11.002 · Cited by 47
Fatty acid synthase inhibition results in a magnetic resonance–detectable drop in phosphocholine
Ross, J. R., Najjar, A. M., Sankaranarayanapillai, M., Tong, W. P., Kaluarachchi, K., & Ronen, S. M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0015 · Cited by 44
Self-citationHirabara, S. M., Silveira, L. R., Abdulkader, F., Alberici, L. C., Procópio, J., Carvalho, C. R. D. O., Pithon‐Curi, T. C., & Curi, R. (2006) · Cell Biochemistry and Function · doi:10.1002/cbf.1327 · Cited by 27
Spurway, T. D., Pogson, C. I., Sherratt, H. S. A., et al. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00103-8 · Cited by 22
Cited by
Cellular Fatty Acid Metabolism and Cancer
Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese, R. V. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.017 · Cited by 2,123
The multifaceted roles of fatty acid synthesis in cancer
Röhrig, F., & Schulze, A. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.89 · Cited by 1,651
Kang, H. M., Ahn, S. H., Choi, P., Ko, Y.-A., Han, S. H., Chinga, F., Park, A. S. D., Tao, J., Sharma, K., Pullman, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3762 · Cited by 1,555
Lipid metabolic reprogramming in cancer cells
Beloribi-Djefaflia, S., Vasseur, S., & Guillaumond, F. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.49 · Cited by 1,398
Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., & Dang, C. V. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0507 · Cited by 1,375
Metadata
- Authors
- Samudio, I., Harmancey, R., Fiegl, M., Kantarjian, H., Konopleva, M., Korchin, B., Kaluarachchi, K., Bornmann, W., Duvvuri, S., Taegtmeyer, H., & Andreeff, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2010-01-04
- Volume
- 120
- Issue
- 1
- Pages
- 142-156
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2088253442
- Cited by
- 709
- References
- 46
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.